TechConnect Wire™

 
Yissum Introduces Novel Nanotechnology for Revolutionizing Imaging Using T-rays
 This invention will make T-ray based cameras and spectrometers practical, ushering a new era in security and medical imaging.
France Biotech Unveils Its Proposals for the French State's National Loan
 Life science must become one of France's strategic development axes
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition
 Pfizer expects to close the transaction on October 15, 2009
Bio-Matrix Scientific Group, Inc. to Aggressively Pursue Private and Public Grants to Fund Research for Development of Stem Cell Treatment of Chronic Obstructive Pulmonary Disease (COPD)
 Initiates Activities by Retaining Grant Development Firm to Source Research Funding
Southwall to Supply Heat Mirror® Insulating Glass for New Line of Owens Corning High Performance Fiberglass Windows
 Energy-Saving Glass Using Heat Mirror Suspended Film Technology to Be Produced by Southwall Joint Venture
Urovalve Receives Additional Funding from NIH to Advance Its Surinate® Urinary Catheter
 Urovalve, Inc. is a privately held company located in the Enterprise Development Center at New Jersey Institute of Technology (NJIT).
SanDisk Ships World’s First Flash Memory Cards with 64 Gigabit X4 (4-Bits-Per-Cell) NAND Flash Technology
 Tel Aviv University had provided a significant contribution to the X4 advanced error correcting and digital signal processing technology, which was licensed exclusively to SanDisk by Ramot at Tel Aviv University Ltd., TAU’s technology transfer company.
University of Florida Formalizes Commitment to Locate Research Facility in Orlando
 Lake Nona Medical City Location Facilitates Collaboration with Burnham Institute
Lamborghini Leads Development of Carbon Fiber with Investment in Aerospace Research and Design Center
 ~ Automobili Lamborghini Advanced Composite Structures Laboratory Opens with Public Unveiling at University of Washington ~
Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates
 - Raises $10M to close first tranche of $25M Financing - Tetraphase Pharmaceuticals was established in August 2006 to advance and commercialize the ground-breaking synthetic chemistry platform developed by internationally recognized chemist, Dr. Andrew Myers of Harvard University.
[ <- 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 -> ]

RSS RSS feed of TechConnect Wire™

Annual Meeting

TechConnect World 2015